Pancreatic cancer has historically had among the lowest survival rates of any type of cancer. A recent study that looked at genomic changes reveals some possible clues.
Academic rigour, journalistic flair
Articles on Chemotherapy
Displaying 21 - 40 of 79 articles
A new breast cancer test predicts whether a patient will benefit from endocrine therapy, allowing patients and their doctors to make better treatment decisions.
Multidisciplinary rehabilitation teams could help cancer survivors to recover from the toxic side-effects of their treatments and return to their lives.
Cancer treatment could be revolutionised by the discovery of the origin cells which divide first.
When you think of viruses, you might think of the horrible illnesses they cause, like flu or Ebola. But now researchers are learning how to use the unique traits of viruses to treat disease.
Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
People across the country show their support for breast cancer patients and survivors by wearing pink and raising money each October. A recent study of patients suggests ways to help all year.
We have no reliable way of knowing which patients’ cancer will return after surgery, so often chemotherapy is given to mop up any remaining cancer cells that may have gone undetected.
While more women than ever are surviving breast cancer, they often do so with bad side effects. Studies are showing that physical therapy early in the post-treatment phase can help.
Patients undergoing chemotherapy are at particular risk from food poisoning - but they aren’t being made aware how critical food safety is at home.
Headlines that 70% of women with breast cancer don’t need chemo need to be heeded with caution: it’s a very specific (but substantial) subtype that was studied.
A cancer is in remission when it can no longer be detected. But we only say it’s cured when it hasn’t come back for a certain time – and that differs for different cancers.
Circadian clocks regulate the timing of hundreds of processes in the cell, suggesting that matching medications with your biological clock could improve the outcome
Cancer doesn’t just grow uncontrollably. It has a smarter strategy than that.
A new silver-based compound that is less toxic with fewer side effects could hold the key to crippling cancer.
Cancer is the second leading cause of death globally. Mathematicians have joined the fight, developing models to both test cancer drug combinations and understand chemotherapy drug resistance.
Great strides have been made in cancer medicine over decades, but it’s important not to forget the growing role that kindness and empathy play in good care.
Improvements in survival rates for acute myeloid leukaemia have failed to keep pace with other leukaemias. That may be about to change.
We need to ensure cancer research addresses what matters most.
Already suffering debilitating side effects, chemotherapy patients could be made seriously ill by the food they eat.
Top contributors
-
Professor and Director Academic Excellence, Macquarie University
-
Research Fellow, ZERO2FIVE Food Industry Centre, Cardiff Metropolitan University
-
Associate Professor (conjoint), Children's Cancer Institute
-
Professor of Sociology, Ball State University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Clinical Instructor, Vanderbilt University
-
Lecturer in Pharmacy, University of Sydney
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
Senior Coordinator, Communications and Events, Monash University
-
Professor, Internal Medicine, University of Michigan
-
Associate Professor of Applied Mathematics, University of Waterloo
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Associate Professor of Behavioral Sciences, University of South Carolina
-
Associate Professor, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Associate Professor of Medicine, Sydney Medical School, Concord Clinical School; Medical Oncologist, Concord Cancer Centre, University of Sydney
